enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time ...

   www.aol.com/glp-1-drugs-no-longer-101500620.html

   Zebound, meanwhile, was the company's fourth-best-selling drug at $1.22 billion in sales in Q2. Another GLP-1 drug, Trulicity, which is also used to treat type 2 diabetes, was its third-best ...

3. Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

   www.aol.com/better-glp-1-biotech-stock-104100464...

   The non-GLP-1 programs mean that it has a lifeline in the very unlikely event that serious problems are discovered that pertain to the entire class of drugs. Altimmune is all in on GLP-1, at least ...

4. Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is ...

   www.aol.com/eli-lilly-shares-fall-glp-111700194.html

   The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion. Recently, however, the stock has been struggling; in the past ...

5. GLP-1 Stocks Aren't the Only Way to Benefit From the ... - AOL

   www.aol.com/finance/glp-1-stocks-arent-only...

   It also has nearly $1.3 billion in cash, cash equivalents, and short-term investments, so it has more than enough resources to continue with the research and development (R&D) of petrelintide as ...

6. Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock ...

   www.aol.com/finance/amgen-vs-viking-therapeutics...

   If the company's GLP-1 treatment, referred to as just VK2735 for now, obtains approval, this already hot stock could become an even more coveted investment to own.

7. 5 weight-loss drug stocks to watch as Ozempic, Zepbound ... - AOL

   www.aol.com/finance/5-weight-loss-drug-stocks...

   The first GLP-1 drug was Byetta (exenatide), approved in 2005 for type 2 diabetes. Almost five years later, Novo Nordisk introduced Victoza (liraglutide), another diabetes drug based on human GLP-1.

8. The FDA is about to make weight-loss drugs a lot harder to get

   www.aol.com/lot-harder-buy-knock-off-090602005.html

   This allowed compounding pharmacies to get into the GLP-1 game by creating their own versions of the injectible drugs using active ingredients obtained from chemical wholesalers and manufacturers ...

9. GLP-1 questions emerge for 2025 - AOL

   www.aol.com/finance/glp-1-questions-emerge-2025...

   GLP-1 questions emerge for 2025. Anjalee Khemlani. December 31, 2024 at 4:48 PM ... The company had indicated it expected higher results, and the stock slid on news of the disappointing results.